OA12709A - Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxa-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-YL)-5-(2-pyridyl)quinzoline. - Google Patents
Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxa-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-YL)-5-(2-pyridyl)quinzoline. Download PDFInfo
- Publication number
- OA12709A OA12709A OA1200400094A OA1200400094A OA12709A OA 12709 A OA12709 A OA 12709A OA 1200400094 A OA1200400094 A OA 1200400094A OA 1200400094 A OA1200400094 A OA 1200400094A OA 12709 A OA12709 A OA 12709A
- Authority
- OA
- OAPI
- Prior art keywords
- formulation
- amino
- pyridyl
- dimethoxy
- methanesulfonamido
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0124455.7A GB0124455D0 (en) | 2001-10-11 | 2001-10-11 | Pharmaceutical formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA12709A true OA12709A (en) | 2006-06-26 |
Family
ID=9923660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200400094A OA12709A (en) | 2001-10-11 | 2002-09-30 | Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxa-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-YL)-5-(2-pyridyl)quinzoline. |
Country Status (33)
| Country | Link |
|---|---|
| EP (1) | EP1434570B8 (is) |
| JP (1) | JP4131471B2 (is) |
| KR (1) | KR20050032510A (is) |
| CN (1) | CN1568180A (is) |
| AP (1) | AP2004003001A0 (is) |
| AR (1) | AR036782A1 (is) |
| AT (1) | ATE303135T1 (is) |
| BR (1) | BR0213196A (is) |
| CA (1) | CA2461168A1 (is) |
| CO (1) | CO5560534A2 (is) |
| DE (1) | DE60205925T2 (is) |
| DK (1) | DK1434570T3 (is) |
| DO (1) | DOP2002000464A (is) |
| EA (1) | EA006168B1 (is) |
| ES (1) | ES2246017T3 (is) |
| GB (1) | GB0124455D0 (is) |
| GT (1) | GT200200184A (is) |
| HR (1) | HRP20040261A2 (is) |
| HU (1) | HUP0600064A3 (is) |
| IL (1) | IL160969A0 (is) |
| IS (1) | IS7179A (is) |
| MA (1) | MA27075A1 (is) |
| MX (1) | MXPA04003293A (is) |
| NO (1) | NO20041520L (is) |
| OA (1) | OA12709A (is) |
| PA (1) | PA8556001A1 (is) |
| PE (1) | PE20030551A1 (is) |
| PL (1) | PL369666A1 (is) |
| PY (1) | PY0223360A (is) |
| SV (1) | SV2004001279A (is) |
| UY (1) | UY27477A1 (is) |
| WO (1) | WO2003032956A1 (is) |
| ZA (1) | ZA200401976B (is) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0317663D0 (en) * | 2003-07-29 | 2003-09-03 | Astrazeneca Ab | Pharmaceutical composition |
| KR102474467B1 (ko) | 2013-03-14 | 2022-12-05 | 암젠 인크 | 복소환식 화합물 및 그들의 용도 |
| KR101943592B1 (ko) | 2017-08-31 | 2019-01-30 | 조현우 | 데이터 마이닝 기법을 이용한 전자가계부 시스템 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69008526T2 (de) * | 1990-07-02 | 1994-08-18 | Bend Res Inc | Asymmetrische mikroporöse Kügelchen für regulierbare Freigabe. |
| FR2752737B1 (fr) * | 1996-08-29 | 1998-10-02 | Synthelabo | Comprime a liberation controlee de chlorhydrate d'alfuzosine |
| GB9700504D0 (en) * | 1997-01-11 | 1997-02-26 | Pfizer Ltd | Pharmaceutical compounds |
| IL141235A (en) * | 2000-02-09 | 2012-04-30 | Novartis Int Pharm Ltd | Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia |
| JP3857919B2 (ja) * | 2000-03-03 | 2006-12-13 | ファイザー・インク | ４−アミノ−６，７−ジメトキシ−２−（５−メタンスルホンアミド−１，２，３，４−テトラヒドロイソキノル−２−イル）−５−（２−ピリジル）キナゾリンメシラートおよび多形 |
-
2001
- 2001-10-11 GB GBGB0124455.7A patent/GB0124455D0/en not_active Ceased
-
2002
- 2002-09-12 DO DO2002000464A patent/DOP2002000464A/es unknown
- 2002-09-17 GT GT200200184A patent/GT200200184A/es unknown
- 2002-09-25 PY PY200200223360A patent/PY0223360A/es unknown
- 2002-09-30 KR KR1020047005316A patent/KR20050032510A/ko not_active Ceased
- 2002-09-30 HU HU0600064A patent/HUP0600064A3/hu unknown
- 2002-09-30 MX MXPA04003293A patent/MXPA04003293A/es active IP Right Grant
- 2002-09-30 PL PL02369666A patent/PL369666A1/xx not_active Application Discontinuation
- 2002-09-30 JP JP2003535760A patent/JP4131471B2/ja not_active Expired - Fee Related
- 2002-09-30 IL IL16096902A patent/IL160969A0/xx unknown
- 2002-09-30 BR BR0213196-0A patent/BR0213196A/pt not_active IP Right Cessation
- 2002-09-30 HR HR20040261A patent/HRP20040261A2/hr not_active Application Discontinuation
- 2002-09-30 AT AT02775048T patent/ATE303135T1/de not_active IP Right Cessation
- 2002-09-30 CN CNA02820042XA patent/CN1568180A/zh active Pending
- 2002-09-30 DK DK02775048T patent/DK1434570T3/da active
- 2002-09-30 ES ES02775048T patent/ES2246017T3/es not_active Expired - Lifetime
- 2002-09-30 CA CA002461168A patent/CA2461168A1/en not_active Abandoned
- 2002-09-30 OA OA1200400094A patent/OA12709A/en unknown
- 2002-09-30 EP EP02775048A patent/EP1434570B8/en not_active Expired - Lifetime
- 2002-09-30 AP APAP/P/2004/003001A patent/AP2004003001A0/en unknown
- 2002-09-30 EA EA200400431A patent/EA006168B1/ru not_active IP Right Cessation
- 2002-09-30 DE DE60205925T patent/DE60205925T2/de not_active Expired - Lifetime
- 2002-09-30 WO PCT/IB2002/004040 patent/WO2003032956A1/en not_active Ceased
- 2002-10-09 AR ARP020103805A patent/AR036782A1/es unknown
- 2002-10-09 PE PE2002000996A patent/PE20030551A1/es not_active Application Discontinuation
- 2002-10-09 UY UY27477A patent/UY27477A1/es not_active Application Discontinuation
- 2002-10-10 SV SV2002001279A patent/SV2004001279A/es not_active Application Discontinuation
- 2002-10-10 PA PA20028556001A patent/PA8556001A1/es unknown
-
2004
- 2004-03-11 ZA ZA200401976A patent/ZA200401976B/en unknown
- 2004-03-11 IS IS7179A patent/IS7179A/is unknown
- 2004-03-18 CO CO04025929A patent/CO5560534A2/es not_active Application Discontinuation
- 2004-04-05 NO NO20041520A patent/NO20041520L/no unknown
- 2004-04-08 MA MA27623A patent/MA27075A1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2464578C (en) | Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient | |
| JP4789806B2 (ja) | パントプラゾール多粒子処方 | |
| US7163696B2 (en) | Pharmaceutical formulations | |
| WO2011111818A1 (ja) | モサプリドまたはその塩を含む徐放型医薬組成物 | |
| JP2002533396A (ja) | 徐放性ガランタミン組成物 | |
| WO2001035958A1 (en) | Carvedilol methanesulfonate | |
| JP2003503341A (ja) | 少なくとも一つの適時パルスを生ずる制御された放出用の医薬投与形態 | |
| KR20040037026A (ko) | 심장병 및 순환성 질병을 치료하고 예방하기 위한 하루1회 요법용 제어방출형 경구 약제학적 조성물 | |
| JP2014501224A (ja) | 口腔内崩壊錠 | |
| JP2013534242A (ja) | ナルブフィンを含有する製剤及びそれらの使用 | |
| EP2317980A2 (en) | Pharmaceutical compositions of rivaroxaban with modified release properties | |
| NO341321B1 (no) | Preparat for oral administrering av tamsulosin-hydroklorid og granul med kontrollert frigivelsesformulering omfattende det samme | |
| WO2016129140A1 (ja) | 口腔内崩壊錠及びその製造方法 | |
| KR20080037680A (ko) | 1-(4-클로로아닐리노)-4-(4-피리딜메틸)프탈라진 및 ｐｈ조절제를 포함하는 고체 제약학적 조성물 | |
| CN101754754B (zh) | 含有包覆的含药物的颗粒的可分散药片及其制备方法 | |
| OA12709A (en) | Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxa-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-YL)-5-(2-pyridyl)quinzoline. | |
| WO2019230937A1 (ja) | 溶出性に優れた経口固形製剤 | |
| WO2011096953A1 (en) | Oral antidepressant formulation with reduced excipient load | |
| JP2018508501A (ja) | タムスロシン塩酸塩含有徐放性顆粒を含む経口用薬剤学的製剤 | |
| AU2002341260A1 (en) | Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl) quinazoline | |
| CA2739611C (en) | Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient | |
| WO2008062426A2 (en) | Formulation of benzazepine derivatives | |
| WO2017102846A1 (en) | Pulsatile release pharmaceutical composition comprising naftazone or one of its salts | |
| HK1091137B (en) | Extended release coated minitablets of venlafaxine hydrochloride | |
| HK1091137A1 (en) | Extended release coated minitablets of venlafaxine hydrochloride |